Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1390777 NEW YORK, NY
Back to ADPT Full portfolio

Position in ADPT

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$0
+$0 QoQ
Shares Held
107,307
+6.8% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $6,393,808,678 across 32 Diagnostics & Research names. ADPT ranks #32 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 3,938,410 $1,974,561,224
2 MTD
Mettler Toledo International Inc/
 596,906 $762,553,373
3 DHR
Danaher Corp /De/
 3,742,518 $712,874,818
4 A
Agilent Technologies, Inc.
 5,233,964 $695,227,423
5 IDXX
Idexx Laboratories Inc /De
 1,193,343 $628,223,477
6 ILMN
Illumina, Inc.
 1,671,192 $293,845,680
7 WAT
Waters Corp /De/
 503,214 $188,725,368
8 IQV
Iqvia Holdings Inc.
 933,111 $180,295,698

All Filings in ADPT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 — 429,229
2026-03-31 — 401,901
2025-12-31 — 413,253
2025-09-30 — 424,509
2025-06-30 — 410,552
2025-03-31 — 358,068
2024-12-31 — 363,906
2024-09-30 — 369,686
2024-06-30 — 460,132
2024-03-31 — 395,344
2023-12-31 — 414,982
2023-09-30 — 375,908
2023-06-30 — 373,583
2023-03-31 — 381,207
2022-12-31 — 391,563
2022-09-30 — 398,331
2022-06-30 — 379,434
2022-03-31 — 905,769
2021-12-31 — 929,187
2021-09-30 — 931,372
2021-06-30 — 905,503
2021-03-31 — 871,575
2020-12-31 — 867,533
2020-09-30 — 783,617
2020-06-30 — 706,335
2020-03-31 — 144,165